Joslin Diabetes Center:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Joslin Diabetes Center - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9320
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Joslin Diabetes Center (Joslin) is a healthcare service provider that offers diabetes treatment, research and education services. The center provides services such as weight management programs, pregnancy program, eye care, diabetes prevention, research, diabetes patient education, adult diabetic care and clinical research studies, among others. It also offers cardiovascular program, exercise, foot care, kidney health, latino clinic, lipids clinic, mental health and counseling services, among others. Joslin provides geriatrics, insulin pump program, peripheral neuropathy clinic, pregnancy program, nutrition programs, pediatrics and sexual function clinic. The center also offers inpatient medical consultations. It provides basic research, clinical research and patient care for both adults and children. Joslin is headquartered in Boston, Massachusetts, the US.

Joslin Diabetes Center – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Joslin Diabetes Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Joslin Diabetes Center, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Joslin Diabetes Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Joslin Diabetes Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Joslin Diabetes Center, Medical Devices Deals, 2012 to YTD 2018 9
Joslin Diabetes Center, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Joslin Diabetes Center, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Sanofi Enters into Co-Development Agreement with Joslin Diabetes Center 11
GI Windows to Enter into Research Agreement with Joslin Diabetes Center 12
Diasome Pharma Enters into Agreement with Joslin Diabetes Center 13
MedImmune Enters into Research Agreement with Joslin Diabetes Center 14
Joslin Diabetes Center Enters Into R&D Agreement With Johnson & Johnson For Diabetes Management 15
Joslin Diabetes Center Enters Into Co-Development Agreement With Pfizer And Lilly 16
Massachusetts Eye & Ear And Joslin Diabetes Center Partner For Eye Care 17
Sanofi Enters Into Co-Development Agreement With Joslin Diabetes Center For Novel Diabetes Drugs 18
Licensing Agreements 19
Ember Therapeutics Enters Into Licensing Agreement With Joslin Diabetes Center For Brown Fat Technology and Intellectual Property 19
Joslin Diabetes Center – Key Competitors 20
Joslin Diabetes Center – Key Employees 21
Joslin Diabetes Center – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Government and Public Interest 23
Jul 23, 2018: Study suggests ways DPP-4 inhibitor might prevent kidney disease 23
Other Significant Developments 24
Aug 02, 2018: Muscle “switch” may control the benefits of exercise 24
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Joslin Diabetes Center, Pharmaceuticals & Healthcare, Key Facts 2
Joslin Diabetes Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Joslin Diabetes Center, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Joslin Diabetes Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Joslin Diabetes Center, Deals By Therapy Area, 2012 to YTD 2018 8
Joslin Diabetes Center, Medical Devices Deals, 2012 to YTD 2018 9
Joslin Diabetes Center, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Sanofi Enters into Co-Development Agreement with Joslin Diabetes Center 11
GI Windows to Enter into Research Agreement with Joslin Diabetes Center 12
Diasome Pharma Enters into Agreement with Joslin Diabetes Center 13
MedImmune Enters into Research Agreement with Joslin Diabetes Center 14
Joslin Diabetes Center Enters Into R&D Agreement With Johnson & Johnson For Diabetes Management 15
Joslin Diabetes Center Enters Into Co-Development Agreement With Pfizer And Lilly 16
Massachusetts Eye & Ear And Joslin Diabetes Center Partner For Eye Care 17
Sanofi Enters Into Co-Development Agreement With Joslin Diabetes Center For Novel Diabetes Drugs 18
Ember Therapeutics Enters Into Licensing Agreement With Joslin Diabetes Center For Brown Fat Technology and Intellectual Property 19
Joslin Diabetes Center, Key Competitors 20
Joslin Diabetes Center, Key Employees 21
Joslin Diabetes Center, Other Locations 22

List of Figures
Joslin Diabetes Center, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Joslin Diabetes Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Joslin Diabetes Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Joslin Diabetes Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Joslin Diabetes Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Joslin Diabetes Center, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Joslin Diabetes Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Joslin Diabetes Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Joslin Diabetes Center, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Joslin Diabetes Center:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Wegmans Food Markets, Inc.:企業の戦略・SWOT・財務分析
    Wegmans Food Markets, Inc. - Strategy, SWOT and Corporate Finance Report Summary Wegmans Food Markets, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Raia Drogasil SA:企業の戦略・SWOT・財務分析
    Raia Drogasil SA - Strategy, SWOT and Corporate Finance Report Summary Raia Drogasil SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Skinvisible Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Skinvisible Pharmaceuticals Inc (Skinvisible Pharmaceuticals), a subsidiary of Skinvisible Inc is a pharmaceutical company that develops and manufactures prescription and over the counter dermatology, medical, cosmetic, consumer goods, and skincare products. The company’s products include an …
  • Famous Brands Limited (Foodservice):企業の戦略・SWOT・財務情報
    Famous Brands Limited (Foodservice) - Strategy, SWOT and Corporate Finance Report Summary Famous Brands Limited (Foodservice) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Fagron NV (FAGR):企業の財務・戦略的SWOT分析
    Summary Fagron NV (Fagron), formerly Arseus NV is a pharmaceutical compounding solution provider. The company offers products such as raw materials, extracts and tinctures, flammable products, anesthesia, ointment bases, syrups, suspension media, triturations, phyto pharmaflore, medispend, capsicard …
  • Avillion Berhad
    Avillion Berhad - Strategy, SWOT and Corporate Finance Report Summary Avillion Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • TETRA Technologies Inc (TTI):石油・ガス:M&Aディール及び事業提携情報
    Summary TETRA Technologies Inc (TETRA) is an oil and gas company that offers completion fluids and associated products and services. The company’s services comprise compression services, fluid, filtration and tools services, offshore services, production testing, rig cooling services, technology cen …
  • Nationwide Building Society:企業の戦略・SWOT・財務分析
    Nationwide Building Society - Strategy, SWOT and Corporate Finance Report Summary Nationwide Building Society - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • AMCON Distributing Company:企業の戦略・SWOT・財務情報
    AMCON Distributing Company - Strategy, SWOT and Corporate Finance Report Summary AMCON Distributing Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Mostostal Warszawa SA (MSW):企業の財務・戦略的SWOT分析
    Mostostal Warszawa SA (MSW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Karlsruhe Institute of Technology:製薬・医療:M&Aディール及び事業提携情報
    Summary Karlsruhe Institute of Technology (KIT) is an educational service provider that offers research based scientific education. The institute offers research programs in the areas of biology, chemistry, and process engineering, mechanical and electrical engineering, physics and mathematics, natu …
  • METRO Retail Stores Group Inc (MRSGI):企業の財務・戦略的SWOT分析
    METRO Retail Stores Group Inc (MRSGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Huawei Technologies Co Ltd:企業の戦略的SWOT分析
    Huawei Technologies Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • First Republic Private Wealth Management:企業の戦略・SWOT・財務情報
    First Republic Private Wealth Management - Strategy, SWOT and Corporate Finance Report Summary First Republic Private Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Datwyler Holding Inc (DAE):企業の財務・戦略的SWOT分析
    Datwyler Holding Inc (DAE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • The Andersons Inc (ANDE):企業の財務・戦略的SWOT分析
    The Andersons Inc (ANDE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Varian Medical Systems Inc (VAR):医療機器:M&Aディール及び事業提携情報
    Summary Varian Medical Systems Inc (VMS) designs, manufactures and sells medical devices and software for the treatment of cancer and other medical conditions through radiotherapy, proton therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy. The company’s major produ …
  • Arup Group Ltd:企業の戦略的SWOT分析
    Arup Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Icahn Enterprises LP:企業のM&A・事業提携・投資動向
    Icahn Enterprises LP - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Icahn Enterprises LP Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Adverum Biotechnologies Inc (ADVM):企業の財務・戦略的SWOT分析
    Summary Adverum Biotechnologies Inc (Adverum) formerly Avalanche Biotechnologies Inc, is a clinical-stage gene therapy provider. The company’s product pipeline includes AVDM-053, ADVM-022 and AVA-311. Its products are used for treatment of antitrypsin deficiency, hereditary angioedema, wet age-relat …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆